article thumbnail

Peloton shares surge as news of PE buyout interest breaks

Private Equity Insights

Shares in Peloton soared by as much as 18% on Tuesday after CNBC reported that several private equity firms are cons idering a buyout of the connected fitness company, which is looking to refinance its debt and return to growth after 13 consecutive quarters of losses. Read more: Private Equity Wire Can’t stop reading?

Buyout 147
article thumbnail

Bain report finds healthcare PE deal value soars in 2024

Private Equity Wire

The report found there are four trends reshaping healthcare PE: Mid-market funds innovate Mid-market healthcare funds, which have outperformed the broader market, continue to innovate and maintain buyout activity and exits since 2020. These funds raised around $59bn since 2022, a 40% increase from the previous three years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Would a Macy's Buyout Be a Miracle on 34th Street?

The Motley Fool

It used to base its buyback plan off book value, and it doesn't use that anymore, for example, but it usually underestimates the company's value. For a company like this to be trading below its book value, it's odd. I'm shaking my head a little bit on this as well.

Buyout 246
article thumbnail

Peloton shares surge as news of PE buyout interest breaks

Private Equity Wire

Shares in Peloton soared by as much as 18% on Tuesday after CNBC reported that several private equity firms are considering a buyout of the connected fitness company, which is looking to refinance its debt and return to growth after 13 consecutive quarters of losses.

Buyout 96
article thumbnail

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?

The Motley Fool

What would a buyout mean for investors? If a company does end up acquiring the CRISPR this year, there are one of two probable scenarios for investors. CRISPR could pay off all of its liabilities, both short and long term, and still have more than $1 billion left in short-term liquid assets. Should you invest in CRISPR stock today?

Investors 246
article thumbnail

Billionaire Jeff Yass Sold 73% of Susquehanna's Stake in Nvidia and Is Piling Into This Beloved Artificial Intelligence (AI) Stock Instead

The Motley Fool

Yass's Susquehanna dumped more than 52 million shares of Nvidia Arguably no public company has been more responsible for lifting Wall Street's major stock indexes to new highs, or fueling the AI revolution, than Nvidia (NASDAQ: NVDA). Since the end of 2022, Nvidia's market cap has catapulted from $360 billion to $3.39

Stakes 246
article thumbnail

3 Artificial Intelligence (AI) Stocks Warren Buffett "Secretly" Owns

The Motley Fool

While the purpose of this transaction was for Berkshire to get its hands on General Re's reinsurance operations, it also owned a specialty investment company at the time: New England Asset Management (NEAM). When Berkshire completed the buyout of General Re, it became the new parent of NEAM. Image source: Getty Images.